About this episode
Jonathan Faison shares his approach to investing in biotech, the 'riskiest' sector (1:35). Recent lows and seeing through the volatility (4:10). Sector winners (9:20). Do sector ETFs make sense? (21:00) Updates on Sutro Biopharma and Voyager Therapeutics (24:15). Show Notes: ROTY Biotech Community Sutro Biopharma: Post ESMO Selloff, Does Their Strategy In FRα Remain Viable? Voyager Therapeutics: CNS Player In Early Stages Of A Turnaround Read the transcripts Black Friday Sale: 20% Off Seeking Alpha. Find the right investment tools to reach your goals!